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Abstract

CONTRIBUTION OF NUCLEIC ACIDS ON THE STRUCTURE OF RECOMBINANT
HEPADNAVIRUS CORE ANTIGENS
By Maimuna Bruce
Bachelors of Science, Virginia Commonwealth University, 2008
A thesis submitted in partial fulfillment of the requirements for the degree of Masters of Science
at Virginia Commonwealth University.
Virginia Commonwealth University, 2010
Major Director: Dr. Darrell Peterson
Professor
Department of Biochemistry and Molecular Biology
The Hepatitis B core antigen (HBcAg) has been proposed to be an ideal candidate for use
as an adjuvant due to its immunogenicity, and tolerance to manipulations such as insertions of
epitopes or covalent attachment of ligands. HBcAg is a complex macromolecule containing
protein and nucleic acid. We investigated the effect of the removal and reconstitution of nucleic
acids upon its structure. It’s been shown that the RNA content of hepadnavirus core antigens can
be reduced significantly, but not be completely removed. Following removal of some of the
RNA, antigens retain the ability to bind added nucleic acids, in particular, "immune-enhancing"
synthetic oligonucleotides without affecting the structure of antigen or disrupting its ability to
spontaneously self-assemble into core particles. The removal and addition of nucleic acids was
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successfully applied to an altered woodchuck core antigen, with a nucleic acid-based malaria
epitope addition, giving rise to a potential vaccine adjuvant platform for malaria.
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Chapter 1: Introduction and Background

Hepatitis
Hepatitis is a cyto-specific archaic disease which affects liver cells, resulting in
inflammation, hepatocellular damage, hepatocellular carcinoma (HCC) and cirrhosis of the liver.
It is caused by five distinct viruses, Hepatitis A, B, C, D, and E (16). Though this group of
viruses all affect the liver, they all belong to independent families, and have very little in
common. They can be found all over the world, with a higher prevalence in the Eastern
hemisphere and third-world countries. The mode of transmission varies from fecal-oral means, to
exposure to infected blood, and unprotected sex with an infected individual. Specifically,
Hepatitis A and Hepatitis E are capable of being transmitted via the fecal-oral pathway, while
Hepatitis B, C and D are blood borne and can be transmitted through sex with infected
individuals (16).
HBV Epidemiology and Pathogenicity
Of these five viruses, Hepatitis B (HBV) can arguably be described as the virus which
impacts the human population the most. Along with Hepatitis C, HBV is responsible for 80% of
HCC cases in the world, which is the fifth most common cancer, and the third leading cause of
all cancer deaths (24). It is estimated that annually, 500,000 to 1,000,000 new cases of HCC are
documented (6).
As mentioned previously, the Hepatitis B virus can be found throughout the world. It is
most endemic throughout Africa, Central and South East Asia, and the Amazon Basin (4) (Figure
1). Contraction of the virus only occurs through contact with infected blood or bodily fluids,
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Figure 1:

Geographic distribution of prevalence of the Hepatitis B Virus. Adapted from
Cooke (3)
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such as semen, and thus can occur through vertical (at the time of birth, not in utero) or
horizontal transmission (4). Vertical infection is more common in areas with higher prevalence.
Horizontal infection, through contact with infected bodily fluids, is the prevalent mode of
transmission in areas where the virus in less common.
Globally there are eight genetically distinct genotypes of Hepatitis B (11). Designated
HBV/A – H. Each of these subtypes dominates various geographical areas, and very often
overlap within these areas (Figure 2) (11). As a criterion for genotype distinction, all genotypes
must have at least an 8% divergence from one another (11). The overlapping and distribution of
the subtypes seen in Figure 2 are thought to be a consequence of human migration (11). Though
there isn’t much evidence to suggest that one subtype is more virulent than another, there have
been some evidence that suggests disease consequences and therapy response may be related to
the genotype involved (11).
Once infected, depending on an infected individual’s immune defense, certain clinical
sequelae may arise. An individual may experience acute hepatitis that may or may not be
accompanied with symptoms. Asymptomatic acute hepatitis can occur if an appropriate immune
response is initiated upon infection while the number of hepatocytes infected is still low (7).
Two-thirds of individuals with acute hepatitis are asymptomatic. The other one-third experiences
clinical symptoms of the disease (11). In these individuals an immune response is mounted,
however, the amount of hepatocytes infected is great enough that their destruction results in
inflammation of the liver (7). Individuals in whom this occurs can experience a barrage of
symptoms such as fever, fatigue, nausea, jaundice and liver failure (11).
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Figure 2:

Geographical distribution of the two main dominant genotypes of HBV for each
region. Adapted from Kramvis et al. (2)
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Three to eight percent of all infected individuals will experience chronic hepatitis
infection, when their immune system is unable to clear the virus. The result is a complicated
relationship between host and virus, initiating a “seesaw” of dominance, where in one instance
the immune system keeps the virus at bay and another instance viral replication will dominate
(7). A consequence of chronic hepatitis infection is persistent clinical symptoms. One-third of
chronically infected individuals will develop HCC, cirrhosis, or end-stage liver disease (11).
Structure, Life cycle, and Serology
The structure of the Hepatitis B Virus has been well studied and characterized. It is a
unique DNA virus with similarities that are reminiscent of retroviruses. There are three different
structures that can be identified, the Dane Particle and two other smaller structures (Figure 3).
These smaller structures are non-infectious and are devoid of any genomic information. They are
spherical structures that are 20 nm in diameter and comprised of viral proteins and lipids from
the host as well as 22 nm wide filaments of variable length. These are referred to as the Hepatitis
B Surface antigen. The Dane particle is the virus (HBV) in its infectious form. It is a 42 nm
spherical particle, consisting of an inner and outer shell. The outer shell is made of noninfectious lipid, recruited from the host, and three lipoproteins containing Hepatitis B Surface
Antigen (HBsAg), known as large pre-S1, middle pre-S2, and major S protein. The inner shell is
made up of another antigen, known as the Hepatitis B Core antigen (HBcAg). The genomic
information of the virus which is a 3.2 kb partially double stranded DNA, and viral polymerase,
can be found inside the capsid formed by the core antigen (Figure 4) (7).
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Figure 3:

HBV Particles. A) HBV virus Dane particle, 40 nm in diameter. B) Spherical
particles found in serum of approximately 20 nm in diameter. C) Filamentous
particles found in serum which can be up to 200 nm in length. Adapted from Hunt
et al (30).
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Figure 4:

Structure and Gene Map of HBV genome. A) Structure of the partially double
stranded relaxed-circular DNA (RC-DNA). B) Gene map of the Hepatitis B
Virus 3.2kb genome. S- Surface Antigen, C: Core and E Antigen, X: X-antigen,
P: P-protein or Polymerase Adapted from Beck et al (1)
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The 3.2kb partially-double stranded DNA has the ability to code for several different
proteins from four different ORFs designated as S, C, P, and X. These open read frames give rise
to the Surface antigen, Core antigen, E antigen, Polymerase, and X antigen. The pre-S1 and preS2 proteins and surface antigen are derived from ORF S, while the Core and E antigen are made
from the ORF C. ORF C has two different, in frame, start codons, known as the pre-core and
core regions. If translation is initiated at the pre-core start codon, the E antigen is made while the
core antigen is made with initiation at the core-region. The peptide produced from the pre-core
region is further modified by the endoplasmic reticulum to produce the E antigen, whose
function is still being studied. The P and X ORFs produce the polymerase or P-protein and X
antigen, respectively (11).
During infection, the Dane Particle first enters hepatocytes through an interaction with a
receptor on the cell, not yet identified in humans (7). This interaction most likely occurs through
the pre-S1 and pre-S2 proteins (7). Viral DNA then enters the cell via an unknown mechanism,
where the viral polymerase, covalently attached to the DNA, converts the partially doublestranded DNA into fully double stranded DNA. In doing so it converts the DNA from a
circularized yet open state, referred to as relaxed-circular DNA (RC-DNA), into covalently
closed circular DNA or cccDNA (1). This reaction also involves cellular enzymes to ligate the
DNA. The P-protein achieves the conversion from RC-DNA to cccDNA via its DNA dependent
DNA synthesis activity (1). Once inside hepatocytes, the viral DNA can begin replication. Hostderived RNA polymerase II is used to transcribe both genomic and subgenomic RNA products
from the cccDNA. mRNA transcribed from the DNA gives rise to all of the HBV proteins. Pregenomic RNA along with the polymerase is encapsulated into new virions. Once packaged the
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polymerase reverse transcribes the RNA into the RC-DNA state via its RNA dependent DNA
synthesis or reverse transcriptase activity. At this point, virions can play two different roles. It
can either perpetuate infection by amplifying the amount of cccDNA or it can be released by the
cell to, in turn, infect other cells.
A distinct serological pattern can be seen in individuals upon infection. After detection of
HBV DNA, the first markers to be identified in the serum are HBsAg and HBeAg. The body is
able to produce antibodies against these viral markers in the form of IgM and IgG
immunoglobulins, (11). The first antibody to be produced is an IgM derived anti-core antigen,
which is present until replaced by IgG derived anti-core antigen (11). Anti-HBeAg and antiHBsAg antibodies are also produced (11). Anti-HBsAg antibody can be detected towards the end
of an infection, and anti-HBeAg antibody can be detected once the virus has been cleared (11).
However, unlike anti-HBeAg antibody, anti-HBcAg and anti-HBsAg antibodies remain within
previously infected hosts throughout their lives (11). This persistence of anti-HBcAg is the basis
for screening blood and blood products for evidence of previous viral infection, while the
protective effect of the anti-HBsAg is the basis for the Hepatitis B Vaccine, which uses purified
recombinant surface antigen to induce an immune response towards the virus (11).
Other Viruses in the hepadnaviridae family
Beyond the Hepatitis B virus that infects human, other hepadnaviruses exist. Currently,
there are related Hepatitis B viruses that can infect woodchucks, pekin ducks, ground squirrels,
woolly monkeys and herons, with the possibility of more yet to be discovered (23). From those
listed, the hepatitis B viruses that infects woodchucks and ducks have been the two, outside of
the human virus, most studied. Though the viruses that infect the woodchuck and duck are in
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different genera, Orthohepadnavirus and Avihepadnavirus, respectively, both are currently
accepted models for hepatitis B infection.
The woodchuck hepatitis B virus (WHBV) is structurally and mechanistically similar to
human HBV. Like human HBV, non-infectious 22 nm filaments and spherical particles of the
same composition can be found in the serum of the infected (23). Infectious particles are 42 nm
to 45 nm in diameter and are structurally identical to human HBV. It contains an outer shell
composed of Hepatitis B surface antigen (WHsAg) with an inner-core capsid made of core
antigen (WHcAg) that houses the virus’s genome and polymerase (23).
Like the WHBV, when compared to the HBV, the duck hepatitis B virus, (DHBV), also
shows a high degree of similarity (9). The infectious virion ranges from 40 nm to 45 nm in
diameter. Like other genera and family members it has an outer core composed of host-derived
lipids and surface antigens, and an inner core that, again, houses the viral genome and
polymerase (9). Non-infectious material can also be detected in the serum during DHBV
infection. However, unlike those found in the serum of the two aforementioned viruses, the noninfectious materials found in the DHBV are larger, non-filamentous, spherical particles ranging
in size from 30 nm to 60 nm in diameter (9). These particles are very similar in appearance to
infectious particles, due to their size, making it hard to distinguish between the two (9).
Hepatitis B Core-antigen
The Hepatitis B Core-antigen, also referred to as HBcAg, is a highly immunogenic
protein (26). It is produced from the HBV core protein gene, which produces both the E-antigen
and core antigen, depending on which initiation site translation begins. Translation from the
second initiation site produces the 22 kilodalton core antigen (28). Both the woodchuck and duck
HBV virus produce very similar core antigen proteins. The duck core antigen, however, is
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slightly larger and is 30 kilodaltons (28). The core antigen can be produced by recombinant DNA
methods, using various systems, including Escherichia coli, while reserving the same
characteristics seen during normal viral replication (26).
The core protein found in human HBV consists of 183 amino acids and has two
conserved functional domains (Figure 5). The nucleic-acid binding domain (amino acid residues
150-183) is located in the C-terminus and is rich with arginine residues. This clustering of
positively charged residues allows the core protein to bind the genomic RNA intermediate of the
virus (12). The assembly domain, amino acid residues 1-149, is responsible for capsid formation
of the inner nucleocapsid found in HBV. The core protein secondary structure primarily consists
of two extended α-helices. HBcAg monomers form dimers via two intermolecular disulfide
bonds with another monomer. (15). Specifically, the disulfide bonds are produced by cysteine
residues 48 and 61, which bond to identical residues (Cys 48 to Cys 48 and Cys 61 to Cys 61)
giving rise to dimerization (15). In addition, Cys-183 forms an additional disulfide bonds with a
Cys-183 residue of a different monomer. and Cys-61 can form various disulfide bounds with
other Cysteines (13, 25, 27). Cys-48 can typically be found either un-bonded with a free
sulfhydryl-group or participating in a disulfide bond, but Cys 61 is always bonded (13,15, 25,
27). The result of this disufide bonding pattern is a highly cross-linked capsid structure.
The dimers are formed spontaneously and arrange into the 180-240 subunit nucleocapsid
both , also known as Capsid-like particles, or CLPs, in vivo and in vitro (26). Dimerization of the
HBcAg monomers results in the display of the α-helices as spikes on the surfaces of the
nucleocapsid. This 28-36 nm icosahedral structure can have either a triangulation number of 3
(180 subunits) or a triangulation number of 4 (240 subunits) (26, 27, 28). When produced in a
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bacterial system, instead of the genomic viral RNA intermediate, the nucleocapsid envelopes
small host-derived bacterial RNAs, which have not been well characterized.
The core antigen can also be produced in a bacterial system, without its nucleic-acid
binding domain. This form of core antigen is referred to as truncated core antigen (Figure 5). The
truncated core antigen loses the ability to bind RNA, but still retains the ability to dimerize and
form icosahedral capsid particles. Figure 5 A-C also shows some of the fundamental properties
of the HBcAg and truncated HBcAg, including molecular weight, isoelectric point, and molar
extinction coefficient. Of particular note is that HBcAg is highly basic, while the truncated
HBcAg is acidic.
Adjuvant potential of HBcAg
As mentioned previously, core antigen is highly immunogenic. All infected individuals
produce high titers of anti-HBcAg. Although the reasons for this are not completely known, one
reason may be the presence of multiple copies of the B-cell epitopes of the antigen. The major Bcell epitope of HBcAg is located at the tip of the spikes present on the surface of the
nucleocapsid, within residues 75-83 (26, 27). Because each nucleocapsid has hundreds of these
spikes, there are many such epitopes displayed on its surface. Moreover, HBcAg has been
shown to convey high immunogenicity on epitopes inserted into its structure.
Due to this trait, it has been of interest to use the core-antigen as an platform for various
epitopes to try to induce protective antibodies and thus immunity to various disease causing
organisms. However, many individuals may have anti-HBcAg antibodies, especially in highly
endemic areas and this may compromise the ability of HBcAg to function as an effective carrier,
as it would be immediately recognized as only HBcAg and attacked by the immune system.
Moreover, the presence of anti-HBcAg is used to screen out potentially infected blood.
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Figure 5:

Amino Acid sequence of the HBV Core antigens
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A)
Human Core
1 MDIDPYKEFG ATVELLSFLP SDFFPSVRDL LDTASALYRE ALESPEHCSP
51 HHTALRQAIL CWGELMTLAT WVGVNELDPG SRDLVVSYVN TNMGLKFRQL
101 LWFHISCLTF GRETVIEYLV SFGVWIRTPP AYRPPNAPIL STLPETTVVR
151 RRGRSPRRRT PSPRRRRSQS PRRRRSQSRE SQC*
Molecular weight = 21101.92
Isoelectric point = 10.69
Extinction coefficient = 29280

Residues = 183

Assembly domain
Nucleic acid binding domain

Truncated Human Core
1 MDIDPYKEFG ATVELLSFLP SDFFPSVRDL LDTASALYRE ALESPEHCSP
51 HHTALRQAIL CWGELMTLAT WVGVNELDPG SRDLVVSYVN TNMGLKFRQL
101 LWFHISCLTF GRETVIEYLV SFGVWIRTPP AYRPPNAPIL STLPETTVV*
Molecular weight = 16830.16
Isoelectric point = 4.80
Extinction coefficient = 29250

Residues = 149
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B)
Woodchuck Core
1 MDIDPYKEFG SSYQLLNFLP LDFFPDLNAL VDTATALYEE ELTGREHCSP
51 HHTAIRQALV CWDELTKLIA WMSSNITSEQ VRTIIVNHVN DTWGLKVRQS
101 LWFHLSCLTF GQHTVQEFLV SFGVWIRTPA PYRPPNAPIL STLPEHTVIR
151 RRGGARASRS PRRRTPSPRR RRSQSPRRRR SQSPSANC
Molecular weight = 21693.46
Isoelectric point = 10.88
Extinction coefficient = 33690

Residues = 188

Assembly domain
Nucleic acid binding domain

Truncated Woodchuck Core
1 MDIDPYKEFG SSYQLLNFLP LDFFPDLNAL VDTATALYEE ELTGREHCSP
51 HHTAIRQALV CWDELTKLIA WMSSNITSEQ VRTIIVNHVN DTWGLKVRQS
101 LWFHLSCLTF GQHTVQEFLV SFGVWIRTPA PYRPPNAPIL STLPEHTVI
Molecular weight = 17266.57 Residues = 149
Average Residue Weight = 115.110 Charged = -6
Isoelectric point = 5.51
Extinction coefficient = 33660
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C)

Duck Core
1 MDINASRALA NVYDLPDDFF PKIDDLVRDA KDALEPYWRS DSIKKHVLIA
51 THFVDLIEDF WQTTQGMHEI AEALRAVIPP TTTPVPAGYL IQHEEAEEIP
101 LGDLFKHQEE RIVSFQPDYP ITARIHAHLK AYAKINEESL DRARRLLWWH
151 YNCLLWGEAN VTNYISRLRT WLSTPERYRG RDAPTIEAIT RPIQVAQGGR
201 KTSSGTRKPR GLEPRRRKVK TTVVYGRRRS KSRDRRAPSP QRAGSPLPRS
251 SSSHRRSPSP RK*
Molecular weight = 30247.00
Isoelectric point = 10.81
Extinction coefficient = 45690

Residues = 262

Assembly domain
Nucleic acid binding domain

Truncated Duck Core
1 MDINASRALA NVYDLPDDFF PKIDDLVRDA KDALEPYWRS DSIKKHVLIA
51 THFVDLIEDF WQTTQGMHEI AEALRAVIPP TTTPVPAGYL IQHEEAEEIP
101 LGDLFKHQEE RIVSFQPDYP ITARIHAHLK AYAKINEESL DRARRLLWWH
151 YNCLLWGEAN VTNYISRLRT WLSTPERYRG RDAPTIEAIT RPIQVAQGGR
201 KTSSGT
Molecular weight = 23747.60
Isoelectric point = 6.10
Extinction coefficient = 44410

Residues = 206
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D)

Malaria Construct (FLW Mal 78 UTC)
1 MDIDPYKEFG SSYQLLNFLP LDFFPDLNAL VDTATALYEE ELTGREHCSP
51 HHTAIRQALV CWDELTKLIA WMSSNITSGI LNANPNVDPN ANPNANPNAN
101 PLEQVRTIIV NHVNDTWGLK VRQSLWFHLS CLTFGQHTVQ EFLVSFGVWI
151 RTPAPYRPPN APILSTLPEH TVIRRRGGAR ASRSPRRGTP SPRRRRSQSP
201 RRRRSQSPSA NCDIEYLNKI QNSLSTEWSP CSVT*
Molecular weight = 26511.64
Isoelectric point = 9.00
Extinction coefficient = 40690

Residues = 234

Assembly domain
Nucleic acid binding domain
Malaria epitope
Universal T cell epitope
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Therefore, the immunization of large numbers of individuals with HBcAg would compromise
this test. Therefore, researchers have focused on the core-antigen of related hepadnavirus, such
as those from duck and woodchuck HBcAg as possible carriers instead of HBcAg.
Furthermore, the core-antigen has great potential as a carrier because it’s easily
manipulated. The spontaneous assembly of particles can occur in the absence of its nucleic-acid
binding domain or without the presence of the disulfide-bonds normally found (27). Chemical
modification of the core-antigen is also possible due to the presence of free sulfhydryl groups,
allowing for the addition of foreign epitopes (27).
Researchers have attempted various approaches to antigen modification, including but
not limited to, adding immunogenic peptide segments, or epitopes, within the protein itself.
However, a drawback is that additions to the amino acid sequence aren’t always well tolerated
and can abolish particle formation, but successful attempts have been documented (26). Other
attempts have focused on manipulation of the bacterial RNA content of particles made by
recombinant DNA methods. It’s known that the RNA content of the HBcAg is approximately
20% by weight, giving rise to an A260/A280 absorbance ratio of 1.5-1.6 due to the absorbance
of the RNA at 260 nm (unpublished, D. Peterson). It has been suggested that this RNA enhances
the immunogenicity of the core particle (2).
Unfortunately, the presence of bacterial RNA has the ability to complicate determination
of the adjuvant potential of the core antigen, and in the case of vaccine formation, its presence
may be undesired (2). Therefore, it is of interest to many researchers to remove this bacterial
RNA and produce RNA-free particles, without abolishing the nucleic-acid binding domain (2).
There is also a need to produce RNA-free particles in order to incorporate other specific immune
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stimulatory synthetic oligonucleotides, again in attempt to enhance the immunogenicity
properties of an HBcAg carrier (5).
The focus of this study is to clearly define the RNA content of the HBcAg's from HBV,
WHBV, and DHBV and to create an affordable and reproducible method of removing RNA from
particles produced in an E. coli system. It is of importance to determine if the removal of the
RNA from particles affects its structural integrity in any fashion. In addition it is of interest to
determine whether, upon RNA removal, an oligonucleotide of a specific sequence can be
incorporated within the particle. Ultimately, it is hoped this information can be to applied to
other antigens such as the modified woodchuck core antigen containing a malaria epitope
insertion at position 78 within its loop region, currently being evaluated as a potential malaria
vaccine candidate (Figure 5). The insertion within the loop region allows presentation of an
amino acid repeat of NANP. This repeat corresponds to one found on the surface coat protein of
the circumsporozoite life stage of the major malaria pathogen, Plasmodium falciparum. The
sporozoite life stage is the stage in which the parasite initially enters human hosts. Immunity to
the coat protein present in this stage could prevent entrance of the parasite into host cells.
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Chapter 2: Methods and Materials
Plasmid Construction
Construction of the plasmids for woodchuck, human and duck Hepatitis B Core antigen
were all achieved by the same method. Nucleotides 1902 through 2805, which corresponds to
the complete full length Hepatitis B Core antigen were cut from the appropriate parent HBV
(ayw)-PBR322 plasmid, using blunt end sites, NlaIII and HhaI sites. A HIND III linker was then
added to the 3’ end of the fragment and the resulting fragment was ligated, in frame, into the
ampicillin-resistant pUC18 plasmid vector using blunt-ended sites SstI and HIND III.
Protein Expression and Purification
Plasmids were either transformed into competent TB1 or Top 10 E. coli cells via heat
shock or electroporation, using electro-competent E. coli cells. These cells were then spread, in
dilutions, on agar plates containing ampicillin. Select colonies were isolated for growth in a 10
ml, ampicillin-containing medium. The cultures were then used to grow 100 ml cultures in the
same medium previously mentioned. From the 100 ml cultures, 10 liters of the bacteria were
grown in either TYN medium (10 g of NZ Amine, 10 g of yeast extract, 5 g of NaCl, and 5 ml of
20% dextrose per liter) or auto-induction medium (100 g N-Z amine, 50 g yeast extract, 7 g
sodium sulfate, 26.5 g ammonium chloride, 67 g dibasic sodium phosphate, 34 g monobasic
potassium phosphate per 10 liters). Using the auto-induction medium, some cell cultures were
grown in large 40 L batches, using a 40 liter yeast bacteria fermenter.
Cell cultures were allowed to grow overnight, for at least 24 hours at 37° C before being
harvested. Cultures were spun down, collected and broken in dilute Tris buffer (10 mM) at high
pressure using an Avestin Emulsiflex operating at a pressure of 15000 psi or greater. Once
broken the cell lysate was heated to 70° C and spun down at 10,000 x g for thirty minutes, and
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the resulting supernatant was collected. An ammonium sulfate precipitation was performed at a
concentration of 277 g per liter of supernatant. This solution was allowed to sit for 30 minutes or
overnight. It was then spun down again at 10,000 x g for 30 minutes and the pellet was collected.
The pellet was re-dissolved in either 25 mM sodium phosphate buffer or 10 mM Tris buffer.
The re-suspended pellet was applied to a Sepharose CL4B column. Ten to fifteen ml
fractions were collected in the same buffer used to re-dissolve the ammonium sulfate pellet. The
absorbance of the fractions at 280 nm was determined using a spectrophotometer. The readings
from the fractions were plotted on a graph and the location of peaks potentially containing the
target protein was determined. Determination of protein location was accomplished through the
use of 12.5% sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS PAGE). Before
being applied to the SDS-PAGE gel, sample buffer containing the reducing agent,
mercaptoethanol, and SDS was added to the samples in order to break disulfide bonds present.
The samples were then heated in water until boiling and applied to the gels.
When the fractions containing the target proteins were confirmed, they were pooled, and
then, depending on the purity of the protein, samples may have been subjected to further
purification methods. The fractions containing the target protein were pooled together and
subjected to a second ammonium sulfate precipitation, again at the concentration of 277 g per
liter. This sample was then spun at 10,000 x g for 30 minutes. The pellet was collected and resuspended using a 10mM Tris-buffer. The re-suspended pellet was dialyzed over-night against
10mM Tris-buffer in order to remove the ammonium sulfate. The purity of the sample was then
confirmed, again, using SDS-PAGE.
Structural Analysis of Proteins
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The structural analyses of the proteins were carried out before and after RNase digestion
of the proteins, and after nucleotide reincorporation. Three methods were used, Circular
dichroism (CD) spectrometry, Absorbance spectrometry, and Dynamic light scattering. In order
to determine the effect RNA and its removal has on the absorbance spectrums of the core
antigens, DHBcAg. WHBcAg, and HBcAg, their truncated counterparts, and the Malaria
construct were scanned, using a spectrophotometer, from wavelengths 220 nm to 300 nm. The
expected absorbance at 280 nm was determined based on the molar extinction coefficient
calculated from the amino acid sequence. The data was then plotted on a graph and adjusted to a
concentration of 1 mg/ml, for the human full length and truncated proteins based on the
calculated absorbance at 280 nm, in order to normalize the data. In addition, the data was
normalized for the woodchuck and duck antigens to allow comparison.
In order to investigate the secondary structure of the antigens, CD spectroscopy was used,
specifically on the woodchuck, human, and Malaria construct core antigens. As previously
stated, this study was done before and after RNase digestion and oligonucleotide addition in
order to determine if any changes to the secondary structure occurred. Proteins were diluted to a
concentration of 0.1 mg/ml and dialyzed into a 20 mM sodium phosphate buffer in order to
eliminate excessive light absorbance a low UV wavelengths caused by the buffer. Proteins were
scanned three times from 190 nm to 160 nm and averaged.
Dynamic light scattering was used in order to investigate particle formation and the size
of the various core antigens. The core antigens were diluted to a concentration of 0.2 mg/ml in a
20 mM sodium phosphate buffer. A minimum of ten readings were collected and averaged to
determine particle size using DynaPro® Protein Solutions molecular sizing instrument and
software.
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RNA Isolation
RNA was extracted and isolated for characterization from wild-type human core antigen
and human core antigen previously subjected to RNase digestion. A modified Trizol® protocol
was used that allowed for extraction and recovery of total RNA from the protein. The extraction
was performed in a laminar flow hood. The RNA was extracted from 3.34 mg – 3.7 mg of the
protein suspension, separated into 1 ml aliquots. The supernatant was poured off and 1ml of
Trizol® was added. The mixture was gently pippetted up and down in order to disrupt the
protein. After a five minute incubation period, 200 µl of chloroform was added and each tube
was shaken for 15 seconds and allowed to incubate for three minutes. The solution was spun
down at 2° C to 8° C for 15 minutes at 12,000 x g. Afterwards, the top aqueous phases were
removed and placed in new tubes. 500 µl of room temperature isopropyl alcohol was added to
the aqueous solution and centrifuged at 12,000 x g for 10 minutes at 2° C to 8° C. The
supernatant was discarded, and the pellet formed was washed with one milliliter of 75% ethanol
and re-spun at 7,500 x g for five minutes. The resulting RNA pellet was then allowed to air dry
before being dissolved in DEPC-treated, RNase free water.
RNA was also isolated using a phenol-chloroform extraction method. Twenty milliliters
of protein at a 3mg/ml concentration was combined with an equal amount of phenol. The RNA
was precipitated using ethanol and incubated for 24 hours at -80 degrees Celsius, then collected
by centrifugation. The pellet was re-dissolved in 5ml of DEPC treated water.
Furthermore, in an attempt to recover RNA with very little to no protein contamination, a
Qiagen RNeasy® kit was used. The manufacturer's protocol for RNA cleanup was used on both
previously extracted RNA, and HBcAg not yet subjected to an extraction protocol.
RNA Characterization
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The spectrum of the extracted RNA was investigated. The absorbance values of the RNA
were evaluated from 220 nm to 300 nm. Additionally the size and purity of the isolated RNA
was investigated. A 10% polyacrylamide gel was run and the RNA was visualized using silver
staining. The A260/A280 absorbance ratio was determined in order to quantify that RNA was
present.
RNase Digestion of Antigens
Establishment of the Procedure
It was of importance to first determine the minimum amount of antigen that could be
loaded on an agarose gel and still be seen by UV fluorescence. Decreasing amounts of HBcAg in
10mM Tris buffer, ranging from 20 µg to 0.025 µg, were run on a 1% agarose gel, containing
ethidium bromide. Next, a digestion time-course experiment was performed to determine the
minimum amount of time and RNase needed for digestion to occur. Varying amounts of RNase
A, ranging from 5 µg to 300 µg, were used for the digestion of 200 µg of HBcAg protein. The
digestion was allowed to proceed up to 48 hours at 37° C. Samples’ sodium chloride
concentration was decreased to 30 mM, and their final volume was increased to 30 µl using
distilled H2O. The degree of digestion, as determined by the intensity of the ethidium bromide
fluorescence upon agarose gel electrophoresis, was checked every 10 minutes for up to 30
minutes. Degree of digestion was checked every 15 minutes from 30 - 120 minutes. Degree of
digestion was checked every 30 minutes from 120 - 300 minutes. Finally, the degree of digestion
was checked every 12 hours from 24 hours – 48 hours.
Next, the effect of pH on digestion was investigated. Five digestions were set up, in
which 50 µg of RNase A was added to 20 µg of HBcAg protein. A control was established as a
sample with the pH of the digestion left unchanged at a pH of 8, while the pHs of the remaining
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four digestions were increased to a pH of 9, 10, 11 or 12. The digestions were allowed to
continue overnight at 37° C.
Digestion Kinetics
The kinetics of the RNase A digestion of the core antigens was followed using a
spectrophotometer. 300 µl of distilled H2O was added to 30 µL of HBcAg at a concentration of
13 mg/ml. 10 µL of a 10X Coating Buffer (10 mM sodium bicarbonate and 10 mM sodium
carbonate), and 25 mM of the reducing agent diothiothreitol, DTT, was also added to increase
the pH and reduce disulfide bonds, respectively. Finally 1 µg of RNase A per 100 µg of protein
was added to the mixture. The absorbance values at 600 nm, 260 nm, and 280 nm was
immediately taken and the spectrometer was then blanked against the digestion solution. The
absorbance values were collected every three seconds for three hours at the wavelengths of 600
nm and 260 nm.
RNase Digestion of Antigens
Larger amounts of WHBcAg and HBcAg were digested using 300 µl of antigen ranging
from a concentration of 6 mg/ml to 13 mg/ml. The antigens were diluted to a volume of 3ml
using water. To increase the pH and disrupt disulfide bonds, 10 µl of 10X Coating Buffer and
50µl of 0.5 M DTT were added to the solution, respectfully. 1 µg of RNase A per 100 µg of
antigen was added last to the solution. The digestion was allowed to proceed for 24 hours at 37°
C. Afterwards antigens were separated from RNase using column chromatography. Digestion
solutions were run on a FPLC size-exclusion column and the core antigen was recovered. If
necessary, proteins were concentrated and the results were assayed using SDS-page
electrophoresis and 1% agarose gel containing ethidium bromide.
Addition of Oligonucleotides
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An attempt to add specific synthetic oligonucleotides to WHBcAg, HBcAg, and the
Malaria Construct (FLWMal78UTC) was made. Using the same digestion protocol just
mentioned, a minimum of 40 ng was added to digestion mixtures before the addition of RNase
A. The same digestion protocol for large amounts of antigen was used. Additionally, the addition
of the oligonucleotide without the RNase digestion was attempted, again, using the same
protocol, and withholding RNase. The oligonucleotide used had the sequence TCC ATG ACG
TTC CTG ATG CT and contained a biotin molecule attached to the 5’ end. After separation on a
FLPC column, the antigens were assayed using SDS-page electrophoresis, electrophoresis on 1%
agarose gel containing ethidium bromide, and with an ELISA assay described below.
A negative and positive control was used for all ELISAs performed. The negative control
was coated with only 50 µl of a 1X coating buffer, and the positive control was coated with a
minimum of 50 ng of the oligonucleotide in 1X coating buffer. The recovered antigens as well as
any peaks found in the UV profile of the fractions from the column were coated into 8 different
well of the plates in 1X coating buffer for two hours. The plate was then washed with distilled
H2O and 100 µl of activated streptavidin-peroxidase conjugate in 2% bovine serum albumin,
BSA, (2 µl streptavidin-peroxidase per 1 ml of BSA), was added and allowed to incubate at
room temperature for an hour. The plates were then washed three times and 50 µl of substrate
(TM Blue) was added to each well of the plate. The reaction was stopped using 100 µl of 1M
phosphoric acid.
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Chapter 3: Results
Protein Plasmid Construction and Expression
The DNA nucleotides corresponding to the core antigens and truncated core antigens for
each species, woodchuck, human, and duck HBV, were successfully ligated, in frame, into a
pUC18 plasmid vector. The plasmid vector for each were transformed into TB1 or Top10 E.
Coli cells, either using heat-shock transformation or electroporation. Either method gave similar
results, producing sufficient colonies on ampicillin-containing agar plates. Large batches were
grown in either TYN or auto-induction medium, both of which effectively induced protein
expression without any noticeable difference in the amount of protein or bacteria produced.
Following disruption by high pressure, the cell lysate was subjected to a heat-step by bringing its
temperature to 70° C. This heat-step denatured most proteins found in the cell lysate, leaving
only a few proteins and the desired HBcAg protein in solution following centrifugation at 15000
x g for 30 min (Figure 6B). The proteins were recovered by ammonium salt precipitation (45%
saturation) and centrifugation. When separated using a Sepharose CL4B column, the targeted
proteins could be found in a second large peak, following a “junk” peak with little to no
contamination (Figure 6A). A 40 liter batch of either the TYN or Auto-Induction media was
capable of producing up to 470 mg of protein which was sufficient for the necessary
experiments.
Structural Analysis of Core Antigens before Digestion
The spectrum of the full length and truncated duck, human, and woodchuck core antigens
were investigated from 220 nm and 300 nm. When compared to each other at 1 mg/ml
differences in absorbance maxima could be seen. The truncated core antigens all had an
absorbance maximum at 280 nm, typical of most proteins. The full-length core antigens had
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Figure 6:

Graph and SDS-page gel of Column Fractions. (a) Absorbance spectrum of
fractions collected from the CL4 column at a wavelength of 280 nm. (b) SDSpage gel of protein extraction. (M) Molecular Weight Marker (L) Lysate (H)
Heated Lysate (A) Ammonium Sulfate precipitation.
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(A)

(B)
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Figure 7:

Normalized spectra of Hepadnavirus Full Length Core Antigens vs Truncated
Core Antigens. (A) Woodchuck Core Antigen. (B) Human Core Antigen. (C)
Duck Core Antigen. Maximums can be seen at the 260 nm for full length core
antigens, and 280 nm for truncated core antigens. These spectra were normalized
to fit on the same scale, and do not represent equal amounts of protein.
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absorbance maximums at 260 nm rather than 280nm, suggesting the presence of nucleic acids
(Figure 7).
The secondary structure of the full length human and woodchuck core antigens were
investigated using circular dichroism spectroscopy (Figure 8). HBcAg as well as WHBcAg both
gave spectra that were indicative of a secondary structure composed of alpha helices. Both
antigens were then analyzed by dynamic light scattering which showed that each was present as
macromolecular particles. The average diameter size was 24.4 nm was for the human core
antigen and 18.34 nm for the woodchuck core antigen (Table 1).
RNA Isolation and Characterization
Using the modified Trizol® extraction method, RNA was extracted directly from
HBcAg. Large pellets were seen and dissolved in 300 µl of DEPC-treated water. A 1:100
dilution was made and the A260/280 absorbance ratio was determined to be 1.7138. Using the
convention of 1 OD corresponding to 40 µg/ml of RNA, it was determined that 1.336 mg of
RNA was extracted from 3.34 mg of protein, or 400µg of RNA per 1 mg of HBcAg. The
spectrum of the RNA from 220 nm to 300 nm was determined and adjusted to correspond to a 1
mg/ml concentration (Figure 9). The RNA had an absorption maximum at 260 nm. RNA was
also isolated from HBcAg previously digested with RNase A using the same protocol in order to
investigate its RNA content after digestion. It was determined that 569.6 µg of RNA was
extracted from 3.7 mg of protein, or 153.94 µg or RNA per 1 mg of digested HBcAg. The RNA
extracted had an A260/280 absorbance ratio of 1.997, indicating little contamination with
protein.
RNA was also extracted using a phenol-chloroform procedure. The phenol-chloroform
extraction produced a substantial pellet that did not go completely into solution when re-
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Figure 8:

Circular Dichroism Spectra (A) Woodchuck Core Antigen (B) Human Core
Antigen. Spectra are indicative of proteins comprised of alpha helices.
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Table 1.

Average diameter size of Hepadnavirus Core particles as determined by dynamic
light scattering.
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Hepadnavirus

Wild-Type

Digested

Woodchuck

18.3 nm

33.9 nm

Oligonucleotide
Added
26.1 nm

Human

24.4 nm

36.4 nm

26.2 nm

Malaria Construct

21.6 nm

25.6 nm

20.5 nm
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Figure 9:

Spectrum of isolated RNA from Human Core Antigen at 1mg/ml
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Figure 10:

Silver-Stained Gel of phenol-chloroform RNA extraction of Human Core
Antigen. Tube 1 contains material from the supernatant and Tube 2 contains
material from the pellet. Red Arrows indicate proteins which stained with
Commassie Blue and Blue arrow RNA stained by silver-staining.
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dissolved in 5 ml of DEPC-treated water. The pellet was partially re-suspended in EB buffer (10
mM Tris-HCl pH 8, 1 mM EDTA), but still did not completely dissolve. Both the resulting
supernatant and un-dissolved pellet were separated on a 10% SDS-PAGE. Components of the
sample were visualized by silver staining (Figure 10). Both samples showed bands of protein that
were visible with commassie blue staining. The supernatant showed a light band of RNA visible
by silver staining. When the re-suspended pellet was separated on an identical gel, followed by
silver-staining, a strong band of RNA was seen at the same position as the RNA present in the
supernatant. Both RNAs were smaller than the available molecular weight markers and its size
being less than 100 bp.
An attempt to further purify the RNA was made using an Qiagen RNeasy® Kit,
specifically, the RNA clean-up protocol. The protocol was used to extract RNA directly from
HBcAg as well as the material from the pellet and supernatant. After the RNeasy® protocol, an
aliquot of the solution was again extracted with phenol-chloroform , to investigate whether this
would further purify the RNA. All products were run on a polyacrylamide gel and visualized by
silver staining. The samples in which the RNeasy® kit and protocol were utilized showed no
presence of RNA (data not shown).
RNase Digestion of Antigens
Using agarose gels and differing amounts of HBcAg, it was determined that a minimum
of 20 µg would be used in RNase digestions. The RNA contained in 5 µg -10 µg of antigen and
stained with ethidium bromide could easily be seen with the naked eye on 1% agarose gels, but
did not show up well in photographs, while 10 µg -20 µg of antigen could both be seen and
photographed well. Antigen concentrations of less than 5 µg produced very weak ethidium
fluorescence, and were hard to detect with the naked eye.
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The time-course experiments revealed that 1µg of RNase per 10 µg of antigen was
sufficient to digest bound RNA after 24 hours. A maximum of 2 µg of RNase per 10 µg of
antigen was also effective for shorter digestion times, of at least 12 hours. An RNase to antigen
ratio higher than this resulted in antigen precipitation. This phenomenon could easily be seen on
an agarose gel because the stainable material did not move out of the sample wells.
HBcAg precipitates from solution at pH values less than 6.5. Therefore it was considered
possible that the digested HBsAg might become insoluble at even higher pH values upon
removal of RNA. Since RNase is active over the pH range of 6-10, the reaction pH was raised as
described in methods and materials in order to determine if its effects would prevent the antigen
from falling out of solution. Each reaction mixture was spun down to pellet any protein that may
have precipitated out of solution. It was determined that an increase of pH to 9 was sufficient in
preventing the antigens from falling out of solution. Reaction mixtures with pH values ranging
from 10-12 also did not form a pellet. Pellet formation was only seen in the reaction mixture with
a neutral pH.
Digestion of RNA by RNase is typically accompanied by an increase in absorbance at
260 nm. This increase is referred to as hyperchromicity, and the increase has been reported to be
between 10% and 40% depending on the RNA. Therefore it was hoped that the digestion of the
RNA in HBcAg could be followed by monitoring the hyperchromicity of the solution versus
time. The kinetics of this digestion for both human and woodchuck antigens demonstrated
similar patterns. When studied at a wavelength of 260 nm, the absorbance of the human antigen
increased very slightly over time (Figure 12). Under the same parameters the absorbance of the
woodchuck antigen also increased very slightly, however, it began to decrease during the latter
part of the digestion (Figure 11). When the digestion was studied at 600 nm the absorbance of
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the human antigen decreased from its beginning absorbance before reaching a minima and
increasing again at absorbance values near that of the original (Figure 12). Similarly, the
absorbance of the woodchuck antigen decreased before reaching minima but instead stabilized
near the minima (Figure 11). Since neither RNA nor protein absorb light at 600 nm, these small
changes must reflect scattering of light, and the results demonstrate that this method cannot be
used to monitor the digestion of the RNA in HBcAg.
When separated on a size-exclusion column, the digestion mixture was resolved into
three peaks of UV absorbing (280 nm) components. When analyzed on a SDS-page gel, the
protein from the first peak displayed the same size as the undigested, wild-type antigen, while
the second peak, co-migrated along with RNase. The third peak did not produce any bands upon
commassie blue staining (Figure 13).

This last peak had an A260/280 ratio typical of

ribonucleotides, and thus was the RNA digestion products. When the samples were run on an
agarose gel, only the first peak produced fluorescence. The A260/280 ratio of the recovered
antigen was markedly decreased from their undigested antigens,
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Figure 11:

Kinetics of Digestion reaction of Woodchuck Core Antigen. (A) Kinetics at a
wavelength of 260nm. (B) Kinetics at a wavelength of 600nm.
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(A)

(B)
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Figure 12:

Kinetics of Digestion reaction of Human Core Antigen. (A) Kinetics at a
wavelength of 260nm. (B) Kinetics at a wavelength of 600nm.
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Figure 13:

Separation of HBcAg using FPLC size-exclusion column filtration. (A)
Chromatograph of UV spectrum of collected fractions. (B) SDS page-gel of
fractions from peaks 1-3. M – Molecular weight marker. O- Original antigen,
undigested. 1 – Separated HBcAg. 2- Separated RNase. 3- Digested RNA
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Table 2:

260/280 absorbance ratio for wild-type, digested and core antigens with the added
oligonucleotide.
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Woodchuck
Human
Malaria Construct

Wild-type

Digested

1.53
1.58
1.44

.907
1.36
1.32

Added
Oligonucleotide
1.07
1.39
1.25
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with values ranging from 1.2-1.4 (Table 2). This decrease could be seen when comparing
undigested and digested antigens upon equal loading on an agarose gel (Figure 14).
When the structures were analyzed, both the human and the woodchuck produced spectra
that deviated slightly from the untreated antigens. Maximum were still found at 260 nm, for the
human core antigen, yet the amount of absorbance at this wavelength was slightly decreased
from that of the original. The woodchuck core antigen maximum shifted from 260 nm to 280 nm
(Figure 15). The CD spectra of the antigens after digestion remained unchanged from that of the
undigested antigen, with spectra still indicative of alpha helices present (Figure 16). After
digestion, particle formation still occurred, however the diameter of the particles increased in
size. The average diameter of HBcAg was 36.42 nm while the average diameter for the
WHBcAg was 33.91 nm. (Table 1)
Addition of Oligonucleotide to Digested Antigen
Both antigens, human and woodchuck, were digested in the presence of the
oligonucleotide, and successfully separated by size-exclusion column chromatography and
recovered. The recovered antigens were analyzed by an ELISA assay as previously mentioned.
As a common convention an absorbance value of two times that of the negative control was
chosen to indicate a positive result. The ELISA plate reader (BIO-RAD SmartSpec 3000) which
was used, reports data in milli-absorbance units, and these are used here. The negative control
of the ELISA for the human antigen had a mean absorbance of 50, and the positive control had a
mean absorbance of 238. The first peak, containing the antigen, had a mean absorbance of 146,
while the remaining three peaks had absorbance values ranging from 50 – 73 (Figure 17A). The
ELISA for the woodchuck antigen showed similar results, with a negative control absorbance
mean value of 35
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Figure 14:

Agarose gel of WHBcAg and HBcAg before and after digestion. 1% Agarose gel
loaded with 42 µg of antigen. Lane 1: WT HBcAg, Lane 2: Digested HBcAg,
Lane 3: Empty, Lane 4: WT WHBcAg, Lane 5: Digested WHBcAg.
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Figure 15:

Absorbance spectrum of Woodchuck and Human core antigens, before and after
digestion. (A) Human Core antigen (B) Woodchuck Core antigen
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(A)

(B)
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Figure 16:

CD spectrum of Woodchuck and Human Core antigen before and after digestion
(A) Human Core antigen. (B) Woodchuck core antigen
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(A)

(B)
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Figure 17:

ELISA assay of HBcAg and WHBcAg. Assay testing for the presence of
biotinylated DNA after digestion in the presence of the biotinylated
Oligonucleotide. (A) Human Core Antigen (B) Woodchuck Core Antigen
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and a mean positive control value of 183. The first peak from the column had a mean value of
113, while the remaining peaks had mean absorbance values no greater than 45 (Figure 17B).
Woodchuck and human antigens not treated with RNase had absorbance values of 55, and 58,
respectively.
When analyzed by agarose gel electrophoresis, an increase in fluorescence in both
antigens could be seen when compared to the digested particles. This fluorescence, however,
remained less than that of the untreated antigens (Figure 18). The presence of the protein was
reconfirmed using an SDS-page gel and when compared to the untreated and digested antigens it
established that the antigens were present and their size was unaffected
Structural Analysis of Antigens with Oligonucleotide addition
The absorbance spectrums of the antigens following oligonucleotide addition did not
deviate greatly from that of the digested or untreated antigens. Maximums were seen near or at
an absorbance value of 260 nm (Figure 19). When analyzed by circular dichroism the spectrum
revealed alpha helices still present and intact. Dynamic light scattering showed the continued
presence of HBcAg particles after the addition of oligonucleotides. When compared to the
digested particles, a decrease in size in both antigens could be seen. HBcAg had an average
particle size of 26.22 nm while WHBcAg had an average particle size of 26.09 nm (Table 1).
Application to Malaria Construct
Structural comparisons
The absorbance spectrum of untreated Malaria Construct followed the same pattern of
that of the woodchuck and human core antigens, with a maximum found at an absorbance value
of 260 nm. The circular dichroism spectrum revealed the presence of alpha helices. Untreated
antigens of the Malaria Construct, when analyzed by dynamic light scattering, formed roughly
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Figure 18:

1% Agarose gel of WHBcAg and HBcAg with Oligonucleotide addition. 1%
Agarose gel of 30 µg of antigens before and after digestion and oligonucleotide
addition. Lane: 1 WT HBcAg, Lane 2: Digested HBcAg, Lane 3: HBcAg with
oligonucleotide, Lane 4: WT WHBcAg, Lane 5: Digested WHBcAg, Lane 6:
WHBcAg with oligonucleotide
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Figure 19:

Absorbance spectrum of Woodchuck and Human core antigens with
oligonucleotide. Before and after digestion and oligonucleotide addition shown.
(A) Human Core antigen (B) Woodchuck Core antigen
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(A)

(B)

72

Figure 20:

CD spectrum of Woodchuck and Human Core antigen before and after Digestion
and oligonucleotide addition (A) Human Core antigen. (B) Woodchuck core
antigen
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(A)

(B)
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the same size particles as HBcAg and WHBcAg with an average particle size of 21.65
nm (Table 1).
After being subjected to RNase digestion, the Malaria Construct was isolated and
recovered from the digestion mixture using a sizing-column. The antigen could be found in the
first peak that came off of the column. Its absorbance spectrum and the spectrum from circular
dichroism did not digress greatly from that of the untreated antigen (Figure 21A). Similarly when
its CD and absorbance spectra were investigated after the addition of the oligonucleotide, there
was very little digression when compared to both the digested and untreated antigen (Figure
21B). Its particle size increased to an average diameter size of 25.60 nm upon treatment with
RNase, and like the human and core antigens, with addition of the oligonucleotide the particle
size decreased to an average size of 20.48 nm.
When the three different methods of antigen treatment were analyzed and compared
against one another on an agarose gel, the same pattern that was observed with the woodchuck
and human antigens was observed. The digested antigen had a decreased fluorescence from that
of the untreated antigen. This fluorescence was partially restored with the addition of the
oligonucleotide, but still remained less than the wild-type antigen (Figure 22A). SDS-page
confirmed that the antigens were present with their sizes unchanged (Figure 22B). The ELISA
confirmed addition of the oligonucleotide to the antigen recovered in the first peak with an
absorbance value of 127.5. Other peaks had absorbance values ranging from 37 to 33. The
antigen that was left in the presence of the oligonucleotide without RNase had an absorbance
value of 104.75 (Figure 23).
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Figure 21:

Absorbance and CD Spectrum of the Malaria Construct core antigen before and
after digestion and oligonucleotide addition. (A) Absorbance Spectrum. (B) CD
Spectrum
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Figure 22:

Agarose gel of Malaria construct and SDS-page gel of all antigens before and
after treatments. (A) 1% Agarose gel of 30µg of the Malaria Construct Core
antigen. Lane 1: Wild-type antigen. Lane 2: Digested antigen. Lane 3: Antigen
with added oligonucleotide.(B) SDS-page gel of all antigens before digestion
(WT), after digestion (D), and after oligonucleotide addition (O). (M) Molecular
weight marker.
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Figure 23:

Biotin ELISA assay of Malaria Construct testing for the presence of biotinylated
DNA after digestion in the presence of the biotinylated oligonucleotide.
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Chapter 4: Discussion
The creation of a functional adjuvant is of great importance for future vaccine creation.
The Hepatitis B Core antigen has been proposed to be an ideal candidate for this purpose due to
its high immunogenicity, ease of production and its tolerance to be experimentally manipulated.
However, in order to realize it’s full potential, its structure and the basis for its high
immunogenicity need to be well understood. One aspect that contributes to both is the RNA
component of the antigen. Therefore the objectives of this study were to determine the
composition of the particles and to elucidate the structural changes that occur in Hepatitis B core
antigens upon removing the nucleic acids, with the goal of adding back specific, defined
oligonucleotides. Our studies suggest that the nucleic acid content of core antigens could be
manipulated and such manipulation resulted in core particles that remained intact, with little
structural changes.
Quantification of the RNA and Protein Content of HBcAg
The problem with trying to quantify the amount of RNA and protein in HBcAg arises
from the difficulty in determining the amount of HBcAg being used. Without knowing the molar
extinction coefficient at a defined wavelength (such as 280 nm) no calculation is possible. One
could weigh the sample following extensive dialysis and drying, but this would require using a
very large amount to obtain accurate weights. However, the spectral properties of the isolated
RNA along with the predicted spectral properties of HBcAg protein can be used to establish a
quantitative measure of RNA and protein.
The truncated HBcAg contains only the protein (Figure 5) and no bound RNA. Its molar
extinction coefficient at 280 nm is readily calculated from the amino acid sequence (Figure 5).
Because the full length HBcAg and the truncated HBcAg have identical amino acid sequences
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except for the lack of the arginine rich nucleic acid binding domain in the case of the truncated
HBcAg, and because they do not differ at all in aromatic residues which contribute to the
absorbance at 280 nm, their absorbance values at 280 and 260 nm should be the same at
equimolar concentrations. This is shown in Figure 5 by the essentially identical molar extinction
coefficients calculated from the amino acid sequences. Thus their A260/A280 ratios should also be
identical. For truncated HBcAg this value is 0.74. This value is similar to other proteins with
the A280 greater than the A260. However, for the full length HBcAg the A260/A280 value is 1.39.
The isolated RNA gave a A260/A280 value of 1.7, which is consistent with reported values of this
ratio for RNA. Because HBcAg has both RNA and protein its spectrum reflects the contribution
of both. Because the relative contribution of each is known, this data can be used to calculate the
fraction of each present in HBcAg.
If one assigns the value x for the fraction of HBcAg that is protein, then 1-x is the
fraction of HBcAg that is RNA. The absorbance at 280 nm is, therefore: ε protein at 280 nm x + εRNAat
. Likewise the absorbance at 260 nm is: εprotein at 260 nm x + εRNAat 260 nm. Where, in each case ε is

280 nm

the extinction coefficient. In this case, the extinction coefficient will be expressed per milligram,
although identical results would result from using the molar extinction coefficients.
Therefore, since the experimentally observed A260/A280 is 1.39 the following relationship
must exist:A260/A280 = (εprotein at 260 nm x + εRNAat 260 nm )/(εprotein at 280 nm x + εRNAat 280 nm) For HBcAg
the calculated values of A260 and A280 for a 1 mg/ml solution would be 0.75 and 1.39
respectively; for truncated HBcAg these values are 0.94 and 1.74 respectively; for RNA these
values are 25 and 14.7 respectively. Therefore for HBcAg the above equation yields: 1.39 =
[0.75x + 25 (1-x)]/([1.39x + 14.7(1-x)] and x = 78.6% protein and 1-x = 21.4% RNA. These
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values are in good agreement with previously reported values. This formula also allows a
reasonable way to determine the amount of RNA remaining after treatments to remove the RNA.
Our studies confirm that HBcAg has RNA associated with it. This was never in doubt.
However, we have developed a simple relationship that allows quantification of the amount of
RNA present using the absorption spectra of the proteins. The value of about 20% RNA and
80% protein is interesting. If one takes the average molecular weight of a ribonucleotide as 339,
then 1 mg of RNA would be about 3 X 10-3 mmol. One the other hand 1 mg of HBcAg protein
is 4.7 X 10-5 mmol. In the nucleotide binding domain there are 16 arginine residues, so in 1 mg
of protein there would be 7.5 X 10-4 mmol of arginine. Each nucleotide would contribute 1
negative charge and each arginine would contribute 1 positive charge to the HBcAg. Therefore
with a ratio of 1:4 for RNA:Protein, these charges would be essentially balanced. (0.25 X 30
compared for the RNA compared to 7.5 for the protein). This explains why HBcAg and tHBcAg
always migrate towards the anode during electrophoresis.
Our evidence suggests that the RNA content can be reduced, though not completely
eliminated upon digestion with RNase A. This can be seen when comparing the absorption
spectrum after digestion to wild-type core particles. A decrease in absorption at 260 nm could be
detected which suggests that a decrease in the nucleic acid content occurred after digestion. In
the case of the woodchuck core antigen, enough nucleic acid was removed so that it began to
resemble its truncated counterpart with an absorption spectrum containing a maximum near 280
nm, although it never becomes the ratio expected for just the protein. We could not, however,
completely remove all of the RNA. But rather, as judged by kinetics studies at 600 nm,
reduction of the RNA content leads to aggregation. Using the digestion parameters that we set,
the 600 nm remained with an absorbance of near zero, until however, increase in either time or
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RNase concentration resulted in an increase of absorbance at 600 nm, suggesting increased
cloudiness of the solution due to aggregated particles falling of solution. This made it impossible
to follow the digestion by hyperchromicity (increase in A260).
Further evidence of the decrease in the RNA content can be seen when comparing the
amount of RNA extracted from the core antigen particles before and after digestion. Before
digestion, 400 µg of RNA per 1 mg of HBcAg was extracted, while after digestion the amount
extracted from the same amount of antigen was 154 µg, a 61% decrease. However, some protein
contamination may be present in either sample as hinted by a 260/280 absorbance ratio of 1.7
and 1.9. However, this decrease still clearly indicates that treatment of particles with RNase
results in a decrease in the RNA content. This decrease in RNA content is further evidenced
through visualization on agarose gels, which showed decreased fluorescence upon RNase
digestion. Analysis of this extracted RNA through silver staining showed that the core antigens
are most likely packaging small bacterial RNA of less than 50 bp in length. The nature of the
packaged RNA currently remains unknown.
Further attempts to determine the amount of RNA digested occurred through the
application of the 260/280 absorbance ratio from the absorption spectrum of the core antigens.
Based on the absorption spectrum of tRNA, we have devised a mathematical formula (Figure 24)
to use the 260/280 ratio of antigens to calculate the RNA and protein content. This formula was
used to create a table listing 260/280 ratio and its corresponding RNA content (Table 3). The
accuracy of the formula is believed to be reasonable because the 260/280 ratio is based on sound
physical parameters of the protein and the purified RNA. Digestion of the human particle
resulted in a decrease of RNA to protein content from approximately 20-25% RNA to 13%
RNA, an overall 48% decrease. The woodchuck antigen decreased from 21% RNA to 10% RNA
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Figure 24:

RNA to Protein formula
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Table 3:

260/280 absorbance ratio and its resulting protein to RNA percentage
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260/280 % Protein
%RNA
1.98
1.935334
98.06467
1.93
22.33651
77.66349
1.88
36.67916
63.32084
1.83
47.31316
52.68684
1.78
55.51228
44.48772
1.73
62.02689
37.97311
1.68
67.32774
32.67226
1.63
71.72515
28.27485
1.58
75.43194
24.56806
1.53
78.59897
21.40103
1.48
81.33611
18.66389
1.43
83.72535
16.27465
1.38
85.82904
14.17096
1.33
87.6955
12.3045
1.28
89.3627
10.6373
1.23
90.86094
9.13906
1.18
92.21467
7.785334
1.13
93.44382
6.556177
1.08
94.56485
5.43515
1.03
95.59141
4.408586
0.98
96.53497
3.465028
0.93
97.4052
2.5948
0.88
98.21033
1.789672
0.83
98.9574
1.042604
0.78
99.65247
0.347534
0.73
100.3008
-0.30079
0.68
100.9069
-0.90692
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and the malaria construct decreased from 17% RNA to 8% RNA, which is a 52% decrease for
both. When analyzing the human core antigen and comparing the 48% decrease calculated from
the 260/280 ratio and 61% decrease determined from the RNA extraction, we can approximate
that nearly half of the RNA content could be removed.
In addition, our data provides evidence that specific nucleic acids can be reincorporated
into hepatitis B core antigen particles during digestion with RNase A. This is strongly supported
by the ELISA results. The biotin molecule attached to the DNA used during digestion was
detected with peroxidase-labeled streptavidin. All core antigens had absorbance values well
above two times that of the negative control, indicating a positive result. This incorporation of
DNA can also be seen when viewing agarose gel which compared antigen that tested positive for
biotin to digested antigen. An increase in absorbance suggests that the nucleic acid content has
also increased. A clear increase in ethidium fluorescence can be detected between the two. When
evaluating the absorption spectrum a slight increase at 260 nm could be seen. Additionally, the
slight increase in the 260/280 ratio supports these findings. It is also important to note that
although only a slight increase in the 260/280 ratio is found, the extinction coefficient for DNA
differs from that of RNA. A 260/280 ratio of ~1.8 is the convention for pure DNA, while the
ratio is ~2.0 for RNA. So even though the change in 260 seems slight it still suggests addition of
DNA. Unlike the woodchuck and human antigens, after oligonucleotide addition the malaria
construct has a 260/280 less than that of the digested particle. This may be due to fluctuation in
the amount of RNA digested away between the two procedures. However, it is still believed that
DNA was incorporated as supported by the ELISA assay, absorption spectrum and increase in
ethidium bromide florescence on an agarose gel.
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Very few changes in the structure of the core antigens were seen upon these
manipulations. The CD spectrum remained the same throughout, indicating that the alpha helices
remained intact and unaffected. Changes in the absorption spectrum of core antigens are
attributed to change in the nucleic acid content. The most notable change in the structure was the
size of the particles. In general, a trend could be seen. The particle sizes increased after digestion
with RNase A, but remained nearly the same size as undigested particles, when digested in the
presence of the oligonucleotide. The decrease in nucleic acid content may give rise to steric
interactions due to the exposure of the positively charge amino acids that originally bound the
nucleic acids. This may cause the particle to expand in size, as exposed charges repel each other,
resulting in a larger diameter. With the oligonucleotide present, this effect may be partially
neutralized as the DNA binds in the place of any RNA digested away, preventing the particle
from expanding.
Our findings, however, seem to contradict some of the findings reported by other
researchers. In one study from Kann and Gerlich et al (10), it was reported that RNase digestion
completely degraded all packaged RNA from human core antigen. This was supported with a
depiction of an agarose gel that contained 1µg of HBcAg per lane. However, in none of the
published reports were spectral data presented, and the amounts of HBcAg used were not
sufficient to warrant their conclusions. Moreover, none demonstrated the production of HBcAg
that would migrate other than towards the anode during electrophoresis, and since the pI of
HBcAg, if it only contained protein is nearly 11, their results are not consistent with removal of
all of the RNA. Our study determined that 1µg of material produced very little fluorescence.
After digestion such a low amount of particle may seemingly produce no fluorescence. In
addition commassie blue staining of the gel produced no protein band, raising questions to
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whether or not the protein was present. A similar situation was also encountered in the study by
Broos (2), who also used a low amount, 5µg, of HBcAg to study the RNA content with an
agarose gel. Again, such a low amount after digestion may seemingly produce no fluorescence.
We hypothesize that recombinant core antigen binds RNA, both, within its capsid and its
outer shell. It may be possible the RNase is too large of a molecule to enter the core capsid and
digest the RNA present. Instead RNase may only be able to digest RNA presented on the outside
of the capsid. Evidence hinting at this phenomenon is the disappearance of a fast moving band of
RNA that is present in undigested core antigens, but not present in digested antigens (See Figure
18). In addition the phenol-chloroform RNA extraction repeatedly reported bands of protein in
an insoluble pellet, which we believe to be denatured protein with RNA still attached to it,
perhaps suggesting an unwillingness of the protein to release its RNA.
Of particular excitement is the indication that synthetic oligonucleotides can be
incorporated into both wild-type and modified core antigens. Our hope is that the chosen
oligonucleotide sequence, TCC ACG TTC CTG ATG CT, with non-methylated CpGs, along
with the presentation of the malaria epitope, will further increase the immunogenicity of the
malaria construct. This increase in immunogenicity may be key to eliciting a large enough
immune response in an organism, in order to induce immunity. However, it still remains
unknown how much of the oligonucleotide is bound to digested core antigens. This knowledge
may be essential to any sequential immunological studies that may follow. The presence of the
RNA handicaps our ability to determine this due to the different extinction coefficients of RNA
and DNA. This makes a simple determination using 260/280 absorbance ratios unlikely.
Future directions include being able to reduce the RNA content of the malaria construct
to that of FDA standards for potential human usage, or removing the RNA content completely.
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In order to accomplish this, the use of other nucleases, such as micrococcal nuclease, may be
employed to test their effectiveness. Another goal is to try to determine the nature of the RNA,
specifically its sequence, base pair size, and what function it may have served in E. coli. It’s of
interest to know whether the RNA packaged by core antigens produced in bacterial systems are
various, random, species of RNA or a specific species of RNA. This knowledge could give us
further insight into the nature of nucleic acids core antigens may or may not preferentially
package.
Finally, such manipulations could be applied to other species of HBcAg. Because a
percentage of the population, vaccinated against or exposed to HBV, may still contain titers of
anti-HBcAg, it usage may not be best suited as a platform for an adjuvant or vaccine carrier for
humans. For this reason the malaria epitope was inserted into the woodchuck core antigen, rather
than the human core antigen. Just like the woodchuck core antigen, the duck, ground squirrel, or
wooly monkey core antigens could be great adjuvant candidates. It’s possible that any one of
these core antigens may be able to tolerate larger or more complex epitope insertions and elicit
just as great or greater immune response in humans. Currently, we hope to begin immunological
studies involving the malaria construct with the added oligonucleotide in order to access its
present effectiveness.
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